熱門資訊> 正文
Collegium宣布1.5亿美元股票回购计划
2025-07-07 20:08
- Collegium (NASDAQ:COLL) has authorized a new share repurchase program to repurchase up to $150 million in common stock through December 31, 2026, replacing previous $150 million share repurchase program authorized in January 2024 which expired on June 30, 2025, which had $65 million remaining under the program.
- As of March 31, 2025, Collegium had approximately 32.1 million shares outstanding.
- Source: Press Release
More on Collegium Pharmaceutical
- Collegium Pharmaceutical: Stock Deserves A 'Buy' Call On Undervaluation Of ADHD Drug
- Collegium Pharmaceutical, Inc. 2025 Q1 - Results - Earnings Call Presentation
- Collegium Pharmaceutical, Inc. (COLL) Q1 2025 Earnings Call Transcript
- Collegium Pharmaceutical enters into accelerated share repurchase agreement
- Collegium pharmaceutical targets $135M in Jornay PM revenue for 2025 amid sales force expansion
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
